Our Division is also a member of the NeuroNEXT through the institution, Dystonia Coalition, and the research network of Parkinson’s Foundation. We have participated in key multicenter observational studies and clinical trials funded by the NIH, NeuroNEXT, Michael J. Fox Foundation, PCORI, and the industry. Our projects benefit from the extensive research infrastructure at the University of Iowa, including the Institute for Clinical and Translational Science, funded by a NIH CTSA program grant for several decades.
Robert Rodnitzky, MD
We have multiple ongoing clinical trials and research projects spanning all aspects of Parkinson’s disease. Starting with Robert Rodnitzky, MD, the founder of our division, we have been a member of the Parkinson Study Group (PSG) and the Huntington Study Group (HSG) since their inception.
Narayanan Lab
The Narayanan lab, funded by NIH grants and philanthropy, studies how Parkinson’s disease affects brain circuits. This research could lead to new therapies for dementia and cognitive dysfunction. They also explore treatments to slow or prevent Parkinson’s progression, with multiple ongoing clinical trials and research projects.
Uc Lab
The Uc lab has been studying cognition, driving, diagnostic biomarkers, and the role of exercise in Parkinson’s disease with funding from the Department of Veterans Affairs, Department of Defense, NIH, and MJFF with extensive collaboration across the campus, including the National Advanced Driving Simulator (NADS).
Jeremy Greenlee, MD
Our excellent DBS neurosurgeon, is a recent recipient of a Presidential Early Career Award for Scientists and Engineers (PECASE) and studies speech generation and effects of DBS with funding from the NIH.